» Articles » PMID: 11703860

Autologous Platelet-rich Plasma Isolated Using the Haemonetics Cell Saver 5 and Haemonetics MCS+ for the Preparation of Platelet Gel

Overview
Journal Vox Sang
Specialty Hematology
Date 2001 Nov 13
PMID 11703860
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Background And Objectives: We compared three methods of isolating platelet-rich plasma (PRP) using the Haemonetics Cell Saver 5 and one method of isolating PRP by plateletpheresis using the Haemonetics MCS+. PRP contains both platelets and fibrinogen, which are used in the preparation of haemostatic agents.

Materials And Methods: When the Haemonetics Cell Saver 5 was used, 500 ml of blood from each of 30 normal volunteer donors was collected into 70 ml of citrate-phosphate-dextrose (CPD) anticoagulant. In a further 14 normal volunteers, the Haemonetics MCS+ was used to isolate PRP by plateletpheresis using an acid citrate dextrose (ACD) to blood ratio of 1 : 9. In a separate study, CPD-anticoagulated whole blood from another 30 volunteers was used for measurement of fibrinogen levels in the plasma and cryoprecipitate.

Results: A larger volume of PRP can be collected using the Haemonetics Cell Saver 5 than by using the Haemonetics MCS+. The platelet concentration and the total number of platelets were higher in the PRP isolated using the Haemonetics MCS+ than in the PRP isolated by the three methods used with the Haemonetics Cell Saver 5, with differences in platelet concentration and PRP volume among the four methods. The mean fibrinogen level in the plasma was 253 mg % +/- 47 (SD) and in the cryoprecipitate was 1085 mg % +/- 304 (SD).

Conclusions: The most appropriate method of PRP isolation for preparation of platelet gel is dependent upon the specific surgical procedure to be undertaken and the patient's needs.

Citing Articles

Assessment of Quality of Platelet-Rich Plasma Produced With Desktop Centrifuge and Comparison With Standardized Commercially Available Platelet-rich plasma.

Srinivasan V, Rekha M, Edsor E, Raja S, Kumar T, Kalaiselvan S J Pharm Bioallied Sci. 2020; 12(Suppl 1):S607-S612.

PMID: 33149529 PMC: 7595503. DOI: 10.4103/jpbs.JPBS_163_20.


Anticoagulants Interfere With the Angiogenic and Regenerative Responses Mediated by Platelets.

Oneto P, Zubiry P, Schattner M, Etulain J Front Bioeng Biotechnol. 2020; 8:223.

PMID: 32266247 PMC: 7098916. DOI: 10.3389/fbioe.2020.00223.


THE USE OF PLATELET RICH PLASMA WITH BONE MARROW ASPIRATE IN PUDDU TIBIAL OSTEOTOMY.

DElia C, Rezende M, Bitar A, Tatsui N, Pecora J, Camanho G Rev Bras Ortop. 2016; 44(6):508-12.

PMID: 27077061 PMC: 4816828. DOI: 10.1016/S2255-4971(15)30149-X.


PLATELET-RICH PLASMA IN ARTHROSCOPIC REPAIRS OF COMPLETE TEARS OF THE ROTATOR CUFF.

Malavolta E, Conforto Gracitelli M, Sunada E, Benegas E, de Santis Prada F, Neto R Rev Bras Ortop. 2016; 47(6):741-7.

PMID: 27047894 PMC: 4799491. DOI: 10.1016/S2255-4971(15)30032-X.


Comparison between Platelet-Rich Plasma and Autologous Iliac Grafts for Tibial Osteotomy.

DElia C, Rezende M, Bitar A, Tatsui N, Pecora J, Hernandez A Cartilage. 2015; 1(4):320-7.

PMID: 26069563 PMC: 4297057. DOI: 10.1177/1947603510376820.